Remodeling <i>Yersinia pseudotuberculosis</i> to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35275791.
- Also identified by DOI 10.1073/pnas.2109667119 and PMC identifier 8931243.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Significance<i>Yersinia pestis</i>, the etiologic agent of plague, has been responsible for high mortality in several epidemics throughout human history. This plague bacillus has been used as a biological weapon during human history and is currently one of the deadliest biological threats. Currently, no licensed plague vaccines are available in the Western world. Since an array of immunogens are enclosed in outer membrane vesicles (OMVs), immune responses elicited by OMVs against a diverse range of antigens may reduce the likelihood of antigen circumvention. Therefore, self-adjuvanting OMVs from a remodeled <i>Yersinia pseudotuberculosis</i> strain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.
Medical subject headings
- Antigens, Bacterial
- Lipid A
- Plague
- Plague Vaccine
- Pore Forming Cytotoxic Proteins
- Yersinia pseudotuberculosis